Home / Medications / Ozempic

Medication guide

Ozempic (semaglutide)

Ozempic is Novo Nordisk's semaglutide brand for type 2 diabetes. It contains the same active ingredient as Wegovy but is approved for different uses and doses.

Updated October 2026

Advertiser disclosure: We may earn a commission from links on this page, at no cost to you. Affiliate disclosure.

Not medical advice: This is general information. Talk to your doctor before starting, stopping or changing any medication. Medical disclaimer.

Key facts

ItemDetails
Active ingredientSemaglutide (GLP-1 receptor agonist)
MakerNovo Nordisk
FormsWeekly pen; doses 0.25, 0.5, 1 and 2 mg
FDA-approved usesImproving blood sugar in adults with type 2 diabetes; reducing cardiovascular risk in adults with type 2 diabetes and heart disease; reducing kidney-related risks in adults with type 2 diabetes and chronic kidney disease
Self-pay price (NovoCare)Pens about $199–$499/mo depending on dose

FDA approval timeline

DateMilestone
December 2017Approved for type 2 diabetes
January 2020Approved to reduce cardiovascular risk in type 2 diabetes
January 2025Approved to reduce kidney-related risks in type 2 diabetes with chronic kidney disease

What the trials found

Ozempic's trials were in people with type 2 diabetes. Weight loss was a secondary outcome at lower doses than Wegovy, so results aren't directly comparable. Using Ozempic for weight loss alone is off-label; a clinician decides which product, if any, is suitable.

Side effects and warnings

Common side effects include nausea, vomiting, diarrhea, stomach pain and constipation. The label carries a boxed warning about thyroid C-cell tumors seen in rodents. See our side effects guide.

Where to get Ozempic

Ozempic needs a prescription. Telehealth programs we review that list it:

ProviderTypical priceOur score
BiltRxCompounded semaglutide from $81/mo; tirzepatide from $129/mo (+ consult and shipping)Our score: 8.4/10

Compare prices in our tracker → · Estimate your monthly cost →

Compounded GLP-1s are not FDA-approved. They are not equivalent to Ozempic. Which medication, if any, is suitable is decided by a licensed clinician.

FAQ

What is Ozempic?

Ozempic is a brand-name prescription medicine made by Novo Nordisk. Its active ingredient is semaglutide.

Is compounded semaglutide the same as Ozempic?

No. Compounded semaglutide is not FDA-approved and is not equivalent to Ozempic. The FDA does not review compounded drugs for safety, effectiveness or quality.

How do I get Ozempic?

Ozempic requires a prescription from a licensed clinician, who decides whether it is suitable for you. Prescriptions can be filled at retail pharmacies, through telehealth programs or at the manufacturer's self-pay pharmacy.

Related guides

  • Wegovy vs Ozempic: Why two semaglutide brands exist, how their doses and approved uses differ, and what each costs to self-pay.
  • Semaglutide vs tirzepatide: How Wegovy and Zepbound differ in how they work, results, side effects and price.
  • GLP-1 costs in 2026: What you'll actually pay for Wegovy, Zepbound, the new pills and compounded versions — with and without insurance.

Sources

GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.

The GLP-1 brief

Price drops, new approvals and provider changes, once a week. No spam, unsubscribe any time.